Total planned funding: $606,907,941
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $129,444,387 |
Mozambique | $116,487,613 |
Zambia | $94,752,911 |
South Africa | $41,244,058 |
Kenya | $29,540,883 |
Vietnam | $25,696,886 |
Burundi | $17,017,043 |
Ethiopia | $14,452,622 |
Zimbabwe | $13,334,391 |
Haiti | $13,164,552 |
India | $12,687,057 |
Tanzania | $11,915,139 |
Côte d'Ivoire | $11,060,855 |
Ghana | $9,732,500 |
Botswana | $8,603,389 |
Indonesia | $7,201,794 |
Malawi | $6,774,109 |
Democratic Republic of the Congo | $6,760,461 |
Papua New Guinea | $5,486,330 |
South Sudan | $5,135,929 |
Eswatini | $4,717,374 |
Rwanda | $4,281,830 |
Asia Regional Program | $3,400,093 |
Uganda | $3,387,400 |
Namibia | $2,707,568 |
Caribbean Region | $2,525,420 |
Angola | $2,466,719 |
Cambodia | $2,025,000 |
Lesotho | $653,628 |
Dominican Republic | $250,000 |
Central Asia Region | $0 |
Organizational Types
NGO | $606,907,941 |
Program Areas
Care | $189,035,343 |
Treatment | $159,143,045 |
Prevention | $158,900,316 |
Governance and Systems | $52,863,946 |
Testing | $46,965,291 |
Budget Codes
HTXS: Treatment: Adult Treatment | $137,364,804 |
HKID: Care: Orphans and Vulnerable Children | $97,053,847 |
HVOP: Sexual Prevention: Other Sexual Prevention | $80,826,037 |
HBHC: Care: Adult Care and Support | $62,983,442 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $52,364,370 |
HVCT: Testing: HIV Testing and Counseling | $46,965,291 |
PDTX: Treatment: Pediatric Treatment | $21,778,241 |
HLAB: Laboratory Infrastructure | $19,741,623 |
OHSS: Health Systems Strengthening | $18,059,187 |
HVSI: Strategic Information | $15,063,136 |
HVTB: Care: TB/HIV | $14,686,177 |
PDCS: Care: Pediatric Care and Support | $14,311,877 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,268,452 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $6,761,832 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $6,556,905 |
HMIN: Biomedical Prevention: Injection Safety | $616,791 |
HMBL: Biomedical Prevention: Blood Safety | $505,929 |
HTXD: Treatment: ARV Drugs | $0 |